Response to the letter to the editor regarding “treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis”
Journal of Bone and Mineral Metabolism · 2026-07 · 44 (4) · 561-561
DOI: 10.1007/s00774-026-01712-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 23.03.2026. Verfasst von Motohiko Sato. Beteiligte Einrichtung: Department of Orthopedics, Inoue Hospital, 16-17, Enoki-cho, Suita, Osaka, 564-0053, Japan. motomotos3@yahoo.co.jp. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Orthopedics, Inoue Hospital, 16-17, Enoki-cho, Suita, Osaka, 564-0053, Japan. motomotos3@yahoo.co.jp.
Zitieren
APA
Sato, M. (2026). Response to the letter to the editor regarding “treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis”. Journal of Bone and Mineral Metabolism, 44(4), 561-561. https://doi.org/10.1007/s00774-026-01712-4
Vancouver
Sato M. Response to the letter to the editor regarding “treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis”. Journal of Bone and Mineral Metabolism. 2026;44(4):561-561. doi:10.1007/s00774-026-01712-4
BibTeX
@article{Sato2026,
author = {Sato, Motohiko},
title = {Response to the letter to the editor regarding “treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis”},
journal = {Journal of Bone and Mineral Metabolism},
year = {2026},
volume = {44},
number = {4},
pages = {561--561},
doi = {10.1007/s00774-026-01712-4}
}
EUVIMED